{Reference Type}: Journal Article
{Title}: Treatment outcomes of patients with primary tracheal tumors - analysis of a large retrospective series.
{Author}: Piórek A;Płużański A;Knetki-Wróblewska M;Winiarczyk K;Tabor S;Teterycz P;Kowalski DM;Krzakowski M;
{Journal}: BMC Cancer
{Volume}: 24
{Issue}: 1
{Year}: 2024 Jun 5
{Factor}: 4.638
{DOI}: 10.1186/s12885-024-12450-z
{Abstract}: <B>OBJECTIVE: </B>Primary tracheal tumors are very rare and their management is not definitely established. Due to its rarity, providing patient care in terms of optimal management poses a considerable challenge. The purpose of this study was to investigate treatment outcomes in patients with these rare tumors.<BR><B>METHODS: </B>We carried out a retrospective analysis of 89 patients with primary tracheal tumors treated at the Maria Sklodowska-Curie National Research Institute of Oncology in Warsaw, Poland, over sixteen years. The study assessed patient demographics, tumor characteristics and treatment. Different treatment options were compared in terms of overall survival, disease-free survival, and progression-free survival.<BR><B>RESULTS: </B>A total of 89 patients were included in the study. In the group presented, 45 patients underwent primary radical treatment and 44 were qualified for palliative treatment. Surgical resection was performed in 13 patients out of radically treated patients. The 5 year OS rates in the group of patients who underwent radical treatment and in the group of patients who underwent palliative treatment were 45.9% and 2.3%, respectively. In the group of patients who underwent radical surgical treatment, the 5 year OS was 76.9% compared to 35.8% in the group of patients who underwent nonsurgical treatment.<BR><B>CONCLUSIONS: </B>A multidisciplinary team should decide treatment options, including in-depth consideration of surgical treatment options.